(19)
(11) EP 4 493 541 A1

(12)

(43) Date of publication:
22.01.2025 Bulletin 2025/04

(21) Application number: 22931274.9

(22) Date of filing: 11.08.2022
(51) International Patent Classification (IPC): 
C07D 209/16(2006.01)
A61K 31/4439(2006.01)
C07D 401/12(2006.01)
A61K 31/4045(2006.01)
A61P 25/00(2006.01)
C07D 405/12(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 209/16
(86) International application number:
PCT/CA2022/051228
(87) International publication number:
WO 2023/173196 (21.09.2023 Gazette 2023/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 18.03.2022 US 202263321440 P
01.06.2022 US 202263347835 P

(71) Applicant: Enveric Biosciences Canada Inc.
Calgary, AB T2L 1Y8 (CA)

(72) Inventors:
  • HAGEL, Jillian M.
    Calgary, Alberta T3G 1P3 (CA)
  • CAI, Ye
    Edmonton, Alberta T6R 0J1 (CA)
  • MATINKHOO, Kaveh
    Calgary, Alberta T2R 1C4 (CA)
  • PRESS, David James
    Calgary, Alberta T3K 1C7 (CA)
  • JENSEN, Glynnis Elizabeth
    Calgary, Alberta T2G 1E5 (CA)
  • FACCHINI, Peter J.
    Calgary, Alberta T3G 1W1 (CA)

(74) Representative: Appleyard Lees IP LLP 
15 Clare Road
Halifax HX1 2HY
Halifax HX1 2HY (GB)

   


(54) C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING